[ET Net News Agency, 6 June 2025] HSBC Global Research raised the target price for CSPC
Pharma (01093) to HKD9.5 from HKD4.7 and upgraded the rating to "buy" from "hold".
The research house said with VBP pressure largely eased, it turns more optimistic on
CSPC's innovative assets. (rc)